Healthcare provider profile · identity verified

Christopher N Compton, MD

Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery · TUCSON, AZ · NPI 1790780880

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Christopher N Compton, MD received $20,497.21 in general payments during 2025 across 43 reported records.

TACTILE SYSTEMS TECHNOLOGY INC accounted for 92.2% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 27 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$20,497.21

43 reported records · 20 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported companyCanonical companyAmountShareRecordsYear
TACTILE SYSTEMS TECHNOLOGY INC Unresolved — no canonical attribution shown $18,899.8792.2%82025
Tactile Systems Technology Inc Unresolved — no canonical attribution shown $601.082.9%72025
Bard Peripheral Vascular, Inc. Unresolved — no canonical attribution shown $201.041.0%32025
Medtronic, Inc. Medtronic, Inc.
exact · evidence 2025-07-22
$162.760.8%52025
AngioDynamics, Inc. Unresolved — no canonical attribution shown $108.170.5%12025
CVRx, Inc. Unresolved — no canonical attribution shown $81.560.4%12025
Koya Medical, Inc. Unresolved — no canonical attribution shown $67.160.3%22025
Shockwave Medical, Inc Unresolved — no canonical attribution shown $41.720.2%12025
Stryker Corporation Unresolved — no canonical attribution shown $41.110.2%22025
W. L. Gore & Associates, Inc. Unresolved — no canonical attribution shown $38.320.2%12025
Cook Medical LLC Unresolved — no canonical attribution shown $36.800.2%22025
LeMaitre Vascular, Inc. Unresolved — no canonical attribution shown $33.700.2%22025
Orthofix Medical, Inc. Unresolved — no canonical attribution shown $29.290.1%12025
Imperative Care, Inc Unresolved — no canonical attribution shown $28.560.1%12025
Abbott Laboratories Unresolved — no canonical attribution shown $25.270.1%12025
Shape Memory Medical Inc. Unresolved — no canonical attribution shown $22.600.1%12025
Terumo Medical Corporation Unresolved — no canonical attribution shown $22.410.1%12025
ASAHI INTECC USA, INC. Unresolved — no canonical attribution shown $20.170.1%12025
Boston Scientific Corporation Unresolved — no canonical attribution shown $19.380.1%12025
Smith+Nephew, Inc. Unresolved — no canonical attribution shown $16.240.1%12025

What were the payments for?

Payment categories

CategoryAmountRecords
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$15,700.005
Travel and Lodging$3,199.873
Food and Beverage$1,597.3435

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported productTypeReported companyRelated amount*RecordsYear
FLEXITOUCH PLUS
Normalized: flexitouch plus
Device TACTILE SYSTEMS TECHNOLOGY INC, Tactile Systems Technology Inc $19,500.95 15 2025
Source payment records
NIMBL
Normalized: nimbl
Device TACTILE SYSTEMS TECHNOLOGY INC, Tactile Systems Technology Inc $19,500.95 15 2025
Source payment records
RotarexS 6 F x 135 cm
Normalized: rotarexs 6 f x 135 cm
Device Bard Peripheral Vascular, Inc. $201.04 3 2025
Source payment records
ENDURANT IIS
Normalized: endurant iis
Device Medtronic, Inc. $132.78 3 2025
Source payment records
AURYON LASER SYSTEM 100-120 VAC
Normalized: auryon laser system 100 120 vac
Device AngioDynamics, Inc. $108.17 1 2025
Source payment records
Barostim Neo System
Normalized: barostim neo system
Device CVRx, Inc. $81.56 1 2025
Source payment records
DAYSPRING
Normalized: dayspring
Device Koya Medical, Inc. $67.16 2 2025
Source payment records
KOYA MEDICAL
Normalized: koya medical
Device Koya Medical, Inc. $67.16 2 2025
Source payment records
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter
Normalized: shockwave ivl system with the shockwave c2 coronary ivl catheter
Device Shockwave Medical, Inc $41.72 1 2025
Source payment records
GORE VIABAHN VBX Balloon Expandable Endo
Normalized: gore viabahn vbx balloon expandable endo
Device W. L. Gore & Associates, Inc. $38.32 1 2025
Source payment records
ZENITH SPIRAL-Z
Normalized: zenith spiral z
Device Cook Medical LLC $36.80 2 2025
Source payment records
XENOSURE BIOLOGIC PATCH
Normalized: xenosure biologic patch
Device LeMaitre Vascular, Inc. $33.70 2 2025
Source payment records
Meridian
Normalized: meridian
Device Orthofix Medical, Inc. $29.29 1 2025
Source payment records
PRODIGY CATHETER
Normalized: prodigy catheter
Device Imperative Care, Inc $28.56 1 2025
Source payment records
ESPRIT
Normalized: esprit
Device Abbott Laboratories $25.27 1 2025
Source payment records
CT THROMBECTOMY SYSTEM KIT
Normalized: ct thrombectomy system kit
Device Stryker Corporation $23.37 1 2025
Source payment records
FLOWTRIEVER CATHETER, S
Normalized: flowtriever catheter s
Device Stryker Corporation $23.37 1 2025
Source payment records
IMPEDE EMBOLIZATION PLUG
Normalized: impede embolization plug
Device Shape Memory Medical Inc. $22.60 1 2025
Source payment records
R2P MISAGO
Normalized: r2p misago
Device Terumo Medical Corporation $22.41 1 2025
Source payment records
Asahi Peripheral Vascular Wires
Normalized: asahi peripheral vascular wires
Device ASAHI INTECC USA, INC. $20.17 1 2025
Source payment records
Varithena Administration Pack
Normalized: varithena administration pack
Device Boston Scientific Corporation $19.38 1 2025
Source payment records
VENASEAL
Normalized: venaseal
Device Medtronic, Inc. $18.27 1 2025
Source payment records
ARTIX MT
Normalized: artix mt
Device Stryker Corporation $17.74 1 2025
Source payment records
"ACTICOAT 4"" X 4"""
Normalized: acticoat 4 x 4
Device Smith+Nephew, Inc. $16.24 1 2025
Source payment records
PICO 7
Normalized: pico 7
Device Smith+Nephew, Inc. $16.24 1 2025
Source payment records
Pico 14
Normalized: pico 14
Device Smith+Nephew, Inc. $16.24 1 2025
Source payment records
TURBOHAWK
Normalized: turbohawk
Device Medtronic, Inc. $11.71 1 2025
Source payment records

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

BrandGenericClaimsBeneficiaries
XareltoRivaroxaban7318
EliquisApixaban3819
ClopidogrelClopidogrel Bisulfate3625
Acetaminophen-CodeineAcetaminophen With Codeine3532
CilostazolCilostazol23suppressed
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav1412
PrednisonePrednisone12suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

YearGeneral PaymentsMain payerExplicit productsCompany overlapsPart D coverage
2025 $20,497.21 · 43 records TACTILE SYSTEMS TECHNOLOGY INC "ACTICOAT 4"" X 4""", ARTIX MT, AURYON LASER SYSTEM 100-120 VAC, Asahi Peripheral Vascular Wires, Barostim Neo System, CT THROMBECTOMY SYSTEM KIT, DAYSPRING, ENDURANT IIS, ESPRIT, FLEXITOUCH PLUS, FLOWTRIEVER CATHETER, S, GORE VIABAHN VBX Balloon Expandable Endo, IMPEDE EMBOLIZATION PLUG, KOYA MEDICAL, Meridian, NIMBL, PICO 7, PRODIGY CATHETER, Pico 14, R2P MISAGO, RotarexS 6 F x 135 cm, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, TURBOHAWK, VENASEAL, Varithena Administration Pack, XENOSURE BIOLOGIC PATCH, ZENITH SPIRAL-Z
2024 Complete

Questions to ask

Questions you could discuss with your doctor

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Loaded source releases

DatasetYearPublicationSource
CMS Open Payments — General Payments 2025 2026-06-30 Original source
Medicare Part D Prescribers by Provider and Drug 2024 2026-05-06 Original source
NPPES Data Dissemination V2 current / reference data 2026-08-10 Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error